BearDownAZ,
Can we expect the same RRR% in BETonMACE for 5 point MACE as we saw in the ASSURE, ASSERT & SUSTAIN trials,... The RRR was 57% for the Diabetic sub group which is much better than the 5 point mace RRR in the Amarin Vascepa trial. I wonder if it the best of any drug,..?
I am wondering if we get a RRR% of around 60% for 5 point MACE would not Apabetalone become very marketable at that point and would not the FDA allow it to marketed for 5 Point MACE,..?
Thanks